CIBC Bancorp USA
MIRM icon

CIBC Bancorp USA’s Mirum Pharmaceuticals MIRM Stock Holding History

CIBC Bancorp USA’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$401K Buy
4,696
+2,073
+79% +$216K ﹤0.01% 1498
2026
Q2 		$307K Buy
+2,623
New +$263K ﹤0.01% 1521
2025
Q3 		$315K Buy
+4,303
New +$274K ﹤0.01% 1059

Other funds holding MIRM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

CIBC Bancorp USA's MIRM Position: Q3 2026 in Review

CIBC Bancorp USA increased its Mirum Pharmaceuticals (MIRM) stake by 79% in Q3 2026, buying an estimated $216K and bringing the position to 4,696 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

CIBC Bancorp USA first reported a position in MIRM in Q3 2025 and has held it in 3 quarters since. 231 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • CIBC Bancorp USA held 4,696 shares of Mirum Pharmaceuticals worth $401K as of Q3 2026.
  • CIBC Bancorp USA bought 2,073 Mirum Pharmaceuticals shares in Q3 2026, an estimated $216K.
  • Mirum Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1498 holding.
  • CIBC Bancorp USA first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 231 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.